Cherry Creek Investment Advisors, Inc.
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1877829
ENGLEWOOD, CO
Position in RXRX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$238,542
+$21,997 QoQ
Shares Held
64,998
-7.9% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#143
of 340 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cherry Creek Investment Advisors, Inc. holds $1,639,883 across 4 Biotechnology names. RXRX ranks #4 (14.5% of the industry book) .
All Filings in RXRX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $238,542 | 64,998 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $216,545 | 70,536 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $272,708 | 66,677 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $325,891 | 66,781 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $324,507 | 64,132 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $336,428 | 63,597 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $419,978 | 62,127 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $377,870 | 57,340 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $700,035 | 93,338 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $573,833 | 57,556 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $176,030 | 17,853 | Shares | Sole | 2024-01-26 | |
| No filing history on record for this holder in this stock. | ||||||